Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients

Nephrology Dialysis Transplantation

Volumn 25, Issue 12, 2010, Pages 4041-4048

  Jung, Ji Yong ^a   Hwang, Young Hwan ^c   Lee, Seong Woo ^b   Lee, Hajeong ^b   Kim, Dong Ki ^b   Kim, Sejoong ^a   Oh, Yun Gyu ^d   Yang, Jaeseok ^b,e   Joo, Kwon Wook ^b   Ahn, Curie ^b,e   Oh, Kook Hwan ^b,e  

^a Gachon University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Eulji General Hospital   (South Korea)

^d Seoul National University Boramae Hospital   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

aortic stiffness; peritoneal dialysis; PWV; serum fetuin A

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; CALCIUM; FETUIN A; PARATHYROID HORMONE; PHOSPHORUS; SERUM ALBUMIN; URIC ACID;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD VESSEL CALCIFICATION; HEART LEFT VENTRICLE MASS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGE FACTORS; AORTA; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD PROTEINS; COHORT STUDIES; DISEASE PROGRESSION; ELASTICITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TRIGLYCERIDES;

EID: 78649495876     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq293     Document Type: Article

References (29)

1. Foley R, Parfrey P, Sarnak M. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119 (Pubitemid 28527268)
2. Wang AY-M, Woo J, Lam CW-K et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: 1676-1685
3. Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439
4. Blacher J, Demuth K, Guerin AP et al. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998; 18: 535-541 (Pubitemid 28177892)
5. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942
6. Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953
7. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740
8. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401
9. Goodman W, Goldin J, Kuizon B et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
10. Adragao T, Pires A, Lucas C et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1480-1488
11. Schafer C, Heiss A, Schwarz A et al. The serum protein α2-Here-mans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366
12. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833
13. Hermans MMH, Brandenburg V, Ketteler M et al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007; 72: 202-207
14. Munakata M, Ito N, Nunokawa T et al. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653-657
15. Kimoto E, Shoji T, Shinohara K et al. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 2003; 52: 448-452
16. Yamashina A, Tomiyama H, Takeda K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364
17. Hermans MMH, Brandenburg V, Ketteler M et al. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant 2006; 21: 1293-1299
18. Stenvinkel P, Wang K, Qureshi AR et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005; 67: 2383-2392
19. Kim J-S, Kang TS, Kim J-B et al. Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients. Atherosclerosis 2007; 192: 401-406
20. Guerin AP, London GM, Marchais SJ et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021
21. Guerin AP, Blacher J, Pannier B et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992
22. Kitahara T, Ono K, Tsuchida A et al. Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 2005; 46: 688-696
23. Raggi P, Bellasi A, Ferramosca E et al. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 2007; 71: 802-807 (Pubitemid 46624028)
24. Oikawa O, Higuchi T, Yamazaki T et al. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. Clin Exp Nephrol 2007; 11: 304-308
25. Ford ML, Tomlinson LA, Smith ER et al. Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4. Nephrol Dial Transplant 2010; 25: 1853-1858
26. Takenaka T, Kobayashi K, Suzuki H. Pulse wave velocity as an indicator of arteriosclerosis in hemodialysis patients. Atherosclerosis 2004; 176: 405-409
27. Shoji T, Nishizawa Y, Kawagishi T et al. Intermediate-density lipo-protein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol 1998; 9: 1277-1284
28. Lundman P, Eriksson MJ, Stuhlinger M et al. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric di-methylarginine. J Am Coll Cardiol 2001; 38: 111-116
29. Lundman P, Eriksson M, Schenck-Gustafsson K et al. Transient tri-glyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997; 96: 3266-3268